Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Home
Profiles
Research units
Research output
Search by expertise, name or affiliation
Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: A network meta-analysis
Kayleigh M. Kew,
Tianjing Li
Bloomberg School of Public Health
Research output
:
Contribution to journal
›
Article
›
peer-review
45
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: A network meta-analysis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Treatment Efficacy
100%
Treatment Options
100%
Chronic Obstructive Pulmonary Disease
100%
Disease Course
100%
Combination Therapy
100%
Short-acting
100%
Network Meta-analysis
100%
β-agonists
100%
Treatment Safety
100%
Inhaled Therapy
100%
Nursing and Health Professions
Obstructive Lung Disease
100%
Beta-Adrenergic Agonist
100%
Network Meta-Analysis
100%
Cholinergic Receptor Blocking Agent
100%
Disease
50%
Combination Therapy
50%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Obstructive Lung Disease
100%
Cholinergic Receptor Blocking Agent
100%
Beta Adrenergic Receptor Stimulating Agent
100%
Disease
50%
Combination Therapy
50%